Possible Offer for OXB – Confidentiality Agreement – Redacted
Possible Offer for OXB – R2.11 Letter – Shareholders
Possible Offer for OXB – R2.11 Letter – Notification of Availability (Email notification)
Possible Offer for OXB – R2.11 Letter – Notification of Availability – Hard Copy
Possible Offer for OXB – R2.11 Letter – Employees
Possible Offer for OXB – R2.11 Letter – Employee Representatives
Enhanced Transcriptional Insulation of Lentiviral Vectors using “Sequence-upgraded PolyA Long Terminal Repeats” or “supA-LTRs”
2.4 Announcement dated 14 January 2026
14th January 2026
Webinar: Optimising Viral Vector Manufacturing with CDMO Expertise and Innovation
18 November 2025
Webinar: Driving Down the Cost- Optimising CGT with the Right CDMO Partner
13 November 2025
Stifel US Healthcare Conference 2025
Jefferies Global Healthcare Conference 2025
